Business
Kane Biotech Announces Results of Annual and Special Meeting of Shareholders
WINNIPEG, Manitoba, July 02, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “...
About this update from Kane Biotech Inc.
Kane Biotech Announces Results of Annual and Special Meeting of Shareholders WINNIPEG, Manitoba, July 02, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) the voting results from its annual and special meeting of shareholders (the “Meeting”) on June 24, 2026. A total of 83,622,028 common shares were represented at the Meeting, representing approximately 46% of the Company’s issued and outstanding common shares (“Common Shares”) as of the record date of the Meeting. All matters voted upon at the Meeting were approved by shareholders, as detailed below. Election of Directors All six nominees listed in the Company’s management information circular dated May 8, 2026 (the “Circular”) were elected as directors of the Company. The voting results are set out below: NomineeVotes For% ForVotes Withheld% WithheldPhilip Renaud75,630,18992.15%6,447,1147.85%John Coleman75,452,28991.93%6,625,0148.07%Robert Huizinga78,297,16895.39%3,780,1354.61%Anne Greven81,794,50399.66%282,8000.35%Shameze Rampertab81,772,38799.63%304,9160.37%David Kideckel77,147,07593.99%4,930,2286.01%      Appointment of Auditor At the Meeting, shareholders approved the appointment of MNP LLP as auditor of the Company for the ensuing year and the directors were authorized to fix the remuneration to be paid to the auditor. Approval of the Fifth Amended and Restated Performance and Restricted Share Unit Plan At the Meeting, shareholders approved the Company’s fifth amended and restated performance and restricted share unit plan (the “Amended and Restated PRSU Plan”). The Company’s board of directors (the “Board”) approved the Amended and Restated PRSU Plan on May 8, 2026. Under the Amended and Restated PRSU Plan, the maximum number of Common Shares that are reserved for issuance is equal to the number of Common Shares representing 10% of the total Common Shares issued and outstanding as at the date of the approval of the Amended and Restated PRSU Plan by the Board, being 18,185,656 Common Shares. A copy of the Amended and Restated PRSU Plan was scheduled to the Circular and is available under the Company’s SEDAR+ profile at www.sedarplus.ca. Approval of the Fourth Amended and Restated St...